These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26021177)

  • 1. [Prescription and follow-up of antithrombotic treatment with vitamin K antagonists].
    Bounhoure JP
    Bull Acad Natl Med; 2013 Nov; 197(8):1561-70; discussion 1570-1. PubMed ID: 26021177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescription and monitoring of anticoagulant therapies].
    Frank M; Fischer AM
    Rev Prat; 2012 Jun; 62(6):849-57. PubMed ID: 22838290
    [No Abstract]   [Full Text] [Related]  

  • 3. [Near-patient testing devices to monitor vitamin K antagonists].
    Brionne-Francois M; Le Querrec A; Lasne D
    Ann Biol Clin (Paris); 2013 Nov; 71():59-69. PubMed ID: 24235329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non valvular atrial fibrillation: the place of the new anticoagulants].
    Pepersack T
    Rev Med Brux; 2015 Sep; 36(4):365-72. PubMed ID: 26591325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of vitamin K antagonists in the elderly].
    Belleville T; Pautas É; Gaussem P; Siguret V
    Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamine K antagonists overdose: Physician adherence to the French guidelines].
    Oliosi E; Pointeau O; Mazoyer E; Le Jeune S; Giroux-Leprieur B; Dhôte R; Mourad JJ
    Rev Med Interne; 2018 May; 39(5):321-325. PubMed ID: 29550092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of thromboembolic and hemorrhagic events in patients with atrial fibrillation under anti-vitamin K.
    Ben Rejeb O; Brahim W; Ghali H; Ernez S; Mahdhaoui A; Jeridi G
    Tunis Med; 2019 Mar; 97(3):432-437. PubMed ID: 31729717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telemedicine can improve the quality of oral anticoagulation using portable devices and self-testing at home.
    Barcellona D; Fenu L; Cornacchini S; Marongiu F
    J Telemed Telecare; 2013 Sep; 19(6):298-301. PubMed ID: 24163291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is the use of vitamin K antagonists harmful in patients with CDK?].
    Pham TT; Saudan P
    Rev Med Suisse; 2012 Feb; 8(330):462-5. PubMed ID: 22452132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patients' knowledge on their vitamin K antagonist treatment.
    Mzoughi K; Zairi I; BenGhorbel F; Ben Kilani M; Kamoun S; Ben Moussa F; Fennira S; Kraiem S
    Tunis Med; 2018 Mar; 96(3):182-186. PubMed ID: 30325485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INR and vitamin K antagonists management by the primary care physicians in Normandy].
    Druilhe L; Humbert X
    Ann Biol Clin (Paris); 2020 Apr; 78(2):157-173. PubMed ID: 32319944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists].
    Cambus JP; Magnin D; Ambid-Lacombe C; Bura A; Desgrippes F; Schneller JM; Benhamou Y; Flaujac C; Horellou MH; De Raucourt E; Kaczan D; Astoul JM; Siguret V
    Rev Med Interne; 2013 Sep; 34(9):515-21. PubMed ID: 23523077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulant clinics in France? Which usefulness now and for the future?].
    Mahé I
    Rev Med Interne; 2013 Sep; 34(9):513-4. PubMed ID: 23517772
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bridging anticoagulation in patients with atrial fibrillation: Is it mandatory ?].
    Hidden-Lucet F
    Rev Med Interne; 2017 Jan; 38(1):1-2. PubMed ID: 27378531
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticoagulation of older patients: what is new?].
    Lafuente-Lafuente C; Pautas É; Belmin J
    Presse Med; 2013 Feb; 42(2):187-96. PubMed ID: 23312927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk stratification in atrial and ventricular arrhythmias].
    Fauchier L; Robin I; de Labriolle A; Poret P; Giraudeau C; Cosnay P; Babuty D
    Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):127-34. PubMed ID: 16792027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications and limitations of anticoagulant treatment in elderly patients].
    Emeriau JP; Decamps A; Dulhoste MN; Labbé T; Bourdel-Marchasson I; Bonnel C; Manciet G
    Rev Prat; 1990 May; 40(15):1375-8. PubMed ID: 2356427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.